Inventor · disambiguated record
Heyue Zhou
Also filed as: ZHOU HEYUE
58 granted patents·20 pending applications·324 citations·filing 2011–2024
98Inventor score
Top patents by PatentIndex Score
78 records- 0197US10058609B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2017·Granted Aug 28, 2018·17 cites·14 claims
- 0296US9175082B2Antigen binding proteins that bind PD-L1ZHOU HEYUE·Filed 2013·Granted Nov 3, 2015·178 cites·5 claims
- 0395US12084503B2Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2) and methods of use thereof for treatmentSORRENTO THERAPEUTICS INC·Filed 2021·Granted Sep 10, 2024·2 cites·18 claims
- 0494US10118963B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2017·Granted Nov 6, 2018·12 cites·17 claims
- 0594US10100118B2Antibody therapeutics that bind CD123SORRENTO THERAPEUTICS INC·Filed 2016·Granted Oct 16, 2018·6 cites·32 claims
- 0692US10800852B2Antibody therapeutics that bind CD38SORRENTO THERAPEUTICS INC·Filed 2018·Granted Oct 13, 2020·3 cites·20 claims
- 0792US9676853B2Antigen binding proteins that bind PD-1SORRENTO THERAPEUTICS INC·Filed 2014·Granted Jun 13, 2017·15 cites·20 claims
- 0891US10377827B2Antigen binding proteins that bind c-metSORRENTO THERAPEUTICS INC·Filed 2013·Granted Aug 13, 2019·14 cites·6 claims
- 0991US10233251B2Antibody therapeutics that bind CD137SORRENTO THERAPEUTICS INC·Filed 2016·Granted Mar 19, 2019·7 cites·19 claims
- 1090US10059774B2Antibody therapeutics that bind CD38SORRENTO THERAPEUTICS INC·Filed 2016·Granted Aug 28, 2018·6 cites·22 claims
- 1189US10035855B2Antibody therapeutics that bind CD47SORRENTO THERAPEUTICS INC·Filed 2016·Granted Jul 31, 2018·8 cites·15 claims
- 1288US10919964B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2018·Granted Feb 16, 2021·2 cites·16 claims
- 1387US11180568B2Antibody therapeutics that bind CD137SORRENTO THERAPEUTICS INC·Filed 2019·Granted Nov 23, 2021·3 cites·19 claims
- 1487US10934361B2Antibody therapeutics that bind CD123SORRENTO THERAPEUTICS INC·Filed 2018·Granted Mar 2, 2021·2 cites·14 claims
- 1586US9902772B2Antibody therapeutics that bind LAG3SORRENTO THERAPEUTICS INC·Filed 2016·Granted Feb 27, 2018·5 cites·10 claims
- 1685US10259881B2Antibody therapeutics that bind CD137GRAY JOHN DIXON·Filed 2016·Granted Apr 16, 2019·4 cites·8 claims
- 1785US2024190959A1Antigen Binding Proteins that Bind PD-L1YUHAN CORP·Filed 2024·Application pending·0 cites
- 1884US11174314B2Anti-KRAS binding proteinsSORRENTO THERAPEUTICS INC·Filed 2019·Granted Nov 16, 2021·2 cites·20 claims
- 1982US10519245B2Antibodies which bind insulin-like growth factor receptor-1 (IGF1R) and methods of use thereof to treat cancerSORRENTO THERAPEUTICS INC·Filed 2013·Granted Dec 31, 2019·6 cites·12 claims
- 2082US9951144B2Antibody therapeutics that bind CD38SORRENTO THERAPEUTICS INC·Filed 2016·Granted Apr 24, 2018·2 cites·4 claims
- 2180US9969807B2Antibody therapeutics that bind CD123GRAY JOHN DIXON·Filed 2016·Granted May 15, 2018·3 cites·20 claims
- 2279US11760806B2CD-38 directed chimeric antigen receptor constructsSORRENTO THERAPEUTICS INC·Filed 2018·Granted Sep 19, 2023·2 cites·18 claims
- 2379US11155623B2Antibody therapeutics that bind CTLA4SORRENTO THERAPEUTICS INC·Filed 2019·Granted Oct 26, 2021·1 cites·8 claims
- 2479US9315579B2Antigen binding proteins that bind CCR2SORRENTO THERAPEUTICS INC·Filed 2013·Granted Apr 19, 2016·3 cites·8 claims
- 2578US10435476B2Antibody therapeutics that bind JAG1SORRENTO THERAPEUTICS INC·Filed 2016·Granted Oct 8, 2019·4 cites·5 claims
- 2677US11878058B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2021·Granted Jan 23, 2024·0 cites·19 claims
- 2777US10584168B2Antigen binding proteins that bind PD-1SORRENTO THERAPEUTICS INC·Filed 2017·Granted Mar 10, 2020·1 cites·7 claims
- 2877US8859740B2Anti-infective binding proteins that bind AIP2KAUFMANN GUNNAR F·Filed 2013·Granted Oct 14, 2014·4 cites·5 claims
- 2976US11919952B2Antigen binding proteins that bind PD-L1YUHAN CORP·Filed 2021·Granted Mar 5, 2024·0 cites·19 claims
- 3075US11746156B2Antibody therapeutics that bind CD123SORRENTO THERAPEUTICS INC·Filed 2021·Granted Sep 5, 2023·0 cites·14 claims
- 3175US10202453B2Antibody therapeutics that bind CTLA4SORRENTO THERAPEUTICS INC·Filed 2016·Granted Feb 12, 2019·1 cites·15 claims
- 3274US11999792B2Antibody therapeutics that bind CD38SORRENTO THERAPEUTICS INC·Filed 2020·Granted Jun 4, 2024·0 cites·20 claims
- 3374US10472413B2Anti-infective binding proteins that bind AIP2SORRENTO THERAPEUTICS INC·Filed 2017·Granted Nov 12, 2019·1 cites·9 claims
- 3474US9873741B2Antibody therapeutics that bind TIM3SORRENTO THERAPEUTICS INC·Filed 2016·Granted Jan 23, 2018·2 cites·19 claims
- 3574US2022025064A1Antibody therapeutics that bind cd137SORRENTO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3674US2022242954A1Antigen Binding Proteins that Bind PD-1SORRENTO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3773US10174107B2Antigen binding proteins that bind delta-like 4 (DLL-4)SORRENTO THERAPEUTICS INC·Filed 2013·Granted Jan 8, 2019·1 cites·28 claims
- 3872US9631009B2Anti-infective binding proteins that bind AIP2SORRENTO THERAPEUTICS INC·Filed 2014·Granted Apr 25, 2017·1 cites·18 claims
- 3971US11155628B2Antigen binding proteins that bind c-MetSORRENTO THERAPEUTICS INC·Filed 2019·Granted Oct 26, 2021·0 cites·18 claims
- 4071US10668148B2Fully human anti-C-X-C chemokine receptor 3 (CXCR3) antibodies and methods of use thereofSORRENTO THERAPEUTICS INC·Filed 2018·Granted Jun 2, 2020·0 cites·14 claims
- 4171US10272154B2Antigen binding proteins that bind WISP1SORRENTO THERAPEUTICS INC·Filed 2015·Granted Apr 30, 2019·1 cites·29 claims
- 4270US9765146B2Fully human anti-CXC chemokine receptor 5 (CXCR5) antibodiesSORRENTO THERAPEUTICS INC·Filed 2015·Granted Sep 19, 2017·1 cites·19 claims
- 4370US2022002415A1Antibody Therapeutics that Bind CTLA4SORRENTO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4469US11242391B2Antigen binding proteins that bind PD-1SORRENTO THERAPEUTICS INC·Filed 2020·Granted Feb 8, 2022·0 cites·7 claims
- 4569US11027012B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2018·Granted Jun 8, 2021·0 cites·10 claims
- 4669US9944707B2Antibodies that bind epidermal growth factor receptor (EGFR)SORRENTO THERAPEUTICS INC·Filed 2013·Granted Apr 17, 2018·1 cites·16 claims
- 4769US9346890B2Antigen binding proteins that bind ErbB3SORRENTO THERAPEUTICS INC·Filed 2013·Granted May 24, 2016·1 cites·4 claims
- 4869US9029510B2Fully human antibodies that bind to VEGFR2 and methods of use thereofGASTWIRT RANDY·Filed 2013·Granted May 12, 2015·1 cites·12 claims
- 4969US2022002422A1Antigen Binding Proteins that Bind c-MetSORRENTO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 5066US10100126B2Antibody therapeutics that bind PSMASORRENTO THERAPEUTICS INC·Filed 2016·Granted Oct 16, 2018·1 cites·8 claims
Showing the top 50 of 78 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Heyue Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →